Abdominal visceral and subcutaneous adipose tissue compartments - Association with metabolic risk factors in the Framingham Heart Study

被引:2187
作者
Fox, Caroline S.
Massaro, Joseph M.
Hoffmann, Udo
Pou, Karla M.
Maurovich-Horvat, Pal
Liu, Chun-Yu
Vasan, Ramachandran S.
Murabito, Joanne M.
Meigs, James B.
Cupples, L. Adrienne
D'Agostino, Ralph B., Sr.
O'Donnell, Christopher J.
机构
[1] NHLBI, Framingham Heart Study, Framingham, MA USA
[2] Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
[4] Boston Univ, Dept Math, Boston, MA 02215 USA
[5] Boston Univ, Sch Publ Hlth, Div Biostat, Boston, MA 02215 USA
[6] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
[7] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA
[8] Semmelweis Univ, H-1085 Budapest, Hungary
[9] Boston Univ, Sch Med, Boston, MA 02215 USA
关键词
abdominal fat; diabetes mellitus; epidemiology; hypertension; intra-abdominal fat; metabolic syndrome X; obesity;
D O I
10.1161/CIRCULATIONAHA.106.675355
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Visceral adipose tissue ( VAT) compartments may confer increased metabolic risk. The incremental utility of measuring both visceral and subcutaneous abdominal adipose tissue ( SAT) in association with metabolic risk factors and underlying heritability has not been well described in a population-based setting. Methods and Results - Participants (n = 3001) were drawn from the Framingham Heart Study (48% women; mean age, 50 years), were free of clinical cardiovascular disease, and underwent multidetector computed tomography assessment of SAT and VAT volumes between 2002 and 2005. Metabolic risk factors were examined in relation to increments of SAT and VAT after multivariable adjustment. Heritability was calculated using variance-components analysis. Among both women and men, SAT and VAT were significantly associated with blood pressure, fasting plasma glucose, triglycerides, and high-density lipoprotein cholesterol and with increased odds of hypertension, impaired fasting glucose, diabetes mellitus, and metabolic syndrome ( P range < 0.01). In women, relations between VAT and risk factors were consistently stronger than in men. However, VAT was more strongly correlated with most metabolic risk factors than was SAT. For example, among women and men, both SAT and VAT were associated with increased odds of metabolic syndrome. In women, the odds ratio ( OR) of metabolic syndrome per 1 - standard deviation increase in VAT ( OR, 4.7) was stronger than that for SAT ( OR, 3.0; P for difference between SAT and VAT < 0.0001); similar differences were noted for men ( OR for VAT, 4.2; OR for SAT, 2.5). Furthermore, VAT but not SAT contributed significantly to risk factor variation after adjustment for body mass index and waist circumference ( P <= 0.01). Among overweight and obese individuals, the prevalence of hypertension, impaired fasting glucose, and metabolic syndrome increased linearly and significantly across increasing VAT quartiles. Heritability values for SAT and VAT were 57% and 36%, respectively. Conclusions - Although both SAT and VAT are correlated with metabolic risk factors, VAT remains more strongly associated with an adverse metabolic risk profile even after accounting for standard anthropometric indexes. Our findings are consistent with the hypothesized role of visceral fat as a unique, pathogenic fat depot. Measurement of VAT may provide a more complete understanding of metabolic risk associated with variation in fat distribution.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 75 条
  • [1] RELATIONSHIPS OF GENERALIZED AND REGIONAL ADIPOSITY TO INSULIN SENSITIVITY IN MEN
    ABATE, N
    GARG, A
    PESHOCK, RM
    STRAYGUNDERSEN, J
    GRUNDY, SM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) : 88 - 98
  • [2] Multipoint quantitative-trait linkage analysis in general pedigrees
    Almasy, L
    Blangero, J
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (05) : 1198 - 1211
  • [3] Arner P, 2001, BIOCHEM SOC T, V29, P72, DOI 10.1042/bst0290072
  • [4] Correlation between serum resistin level and adiposity in obese individuals
    Azuma, K
    Katsukawa, F
    Oguchi, S
    Murata, M
    Yamazaki, H
    Shimada, A
    Saruta, T
    [J]. OBESITY RESEARCH, 2003, 11 (08): : 997 - 1001
  • [5] Adiponectin in youth -: relationship to visceral adiposity, insulin sensitivity, and β-cell function
    Bacha, F
    Saad, R
    Gungor, N
    Arslanian, SA
    [J]. DIABETES CARE, 2004, 27 (02) : 547 - 552
  • [6] PORTAL ADIPOSE-TISSUE AS A GENERATOR OF RISK-FACTORS FOR CARDIOVASCULAR-DISEASE AND DIABETES
    BJORNTORP, P
    [J]. ARTERIOSCLEROSIS, 1990, 10 (04): : 493 - 496
  • [7] Visceral adiposity and risk of type 2 diabetes - A prospective study among Japanese Americans
    Boyko, EJ
    Fujimoto, WY
    Leonetti, DL
    Newell-Morris, L
    [J]. DIABETES CARE, 2000, 23 (04) : 465 - 471
  • [8] Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome
    Carr, DB
    Utzschneider, KM
    Hull, RL
    Kodama, K
    Retzlaff, BM
    Brunzell, JD
    Shofer, JB
    Fish, BE
    Knopp, RH
    Kahn, SE
    [J]. DIABETES, 2004, 53 (08) : 2087 - 2094
  • [9] Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men
    Cigolini, M
    Targher, G
    Andreis, IAB
    Tonoli, M
    Agostino, G
    DeSandre, G
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (03) : 368 - 374
  • [10] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497